Overall, the obtained data suggest that the identification of mechanisms involved in NGB release or activated by exogenous globin may open new avenue in the definition of targetable pathways for breast cancer treatment, enlarging our point of view outside the single cell response but looking at cell-cell homotypic and heterotypic communication. This evidence concerns the gene NGB and breast cancer.